Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins
Abstract The safety and efficacy of several life-saving therapeutic proteins are compromised due to their immunogenicity. Once a sustained immune response against a protein-based therapy is established, clinical options that are safe and cost-effective become limited. Prevention of immunogenicity of...
Guardado en:
Autores principales: | Nhan H. Nguyen, Fiona Y. Glassman, Robert K. Dingman, Gautam N. Shenoy, Elizabeth A. Wohlfert, Jason G. Kay, Richard B. Bankert, Sathy V. Balu-Iyer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1786baa1e47743e4a012fbcf4ceadcfd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments
por: Gautam N. Shenoy, et al.
Publicado: (2021) -
Particle platforms for cancer immunotherapy
por: Serda RE
Publicado: (2013) -
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
por: Lanying Du, et al.
Publicado: (2016) -
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments
por: Hans Minderman, et al.
Publicado: (2021) -
Rational design of universal immunotherapy for TfR1-tropic arenaviruses
por: Hadas Cohen-Dvashi, et al.
Publicado: (2020)